FDA lifts clinical hold on Peninsula company's off-the-shelf cancer cell therapy trial
January 11, 2022 at 09:24 AM EST
The FDA three months ago placed a clinical hold on the company's cancer cell therapy trials after finding an "chromosomal abnormality."
